4.7 Article

Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome The AIRWAYS-2 Randomized Clinical Trial

Journal

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 320, Issue 8, Pages 779-791

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2018.11597

Keywords

-

Funding

  1. National Institute for Health Research (NIHR) Health Technology Assessment Programme [12/167/102]
  2. NIHR Comprehensive Research Networks

Ask authors/readers for more resources

IMPORTANCE The optimal approach to airway management during out-of-hospital cardiac arrest is unknown. OBJECTIVE To determine whether a supraglottic airway device (SGA) is superior to tracheal intubation (TI) as the initial advanced airway management strategy in adults with nontraumatic out-of-hospital cardiac arrest. DESIGN, SETTING, AND PARTICIPANTS Multicenter, cluster randomized clinical trial of paramedics from 4 ambulance services in England responding to emergencies for approximately 21 million people. Patients aged 18 years or older who had a nontraumatic out-of-hospital cardiac arrest and were treated by a participating paramedic were enrolled automatically under a waiver of consent between June 2015 and August 2017; follow-up ended in February 2018. INTERVENTIONS Paramedics were randomized 1: 1 to use TI (764 paramedics) or SGA (759 paramedics) as their initial advanced airway management strategy. MAIN OUTCOMES AND MEASURES The primary outcome was modified Rankin Scale score at hospital discharge or 30 days after out-of-hospital cardiac arrest, whichever occurred sooner. Modified Rankin Scale score was divided into 2 ranges: 0-3 (good outcome) or 4-6 (poor outcome; 6 = death). Secondary outcomes included ventilation success, regurgitation, and aspiration. RESULTS A total of 9296 patients (4886 in the SGA group and 4410 in the TI group) were enrolled (median age, 73 years; 3373 were women [36.3%]), and the modified Rankin Scale score was known for 9289 patients. In the SGA group, 311 of 4882 patients (6.4%) had a good outcome (modified Rankin Scale score range, 0-3) vs 300 of 4407 patients (6.8%) in the TI group (adjusted risk difference [RD], -0.6%[95% CI, -1.6% to 0.4%]). Initial ventilation was successful in 4255 of 4868 patients (87.4%) in the SGA group compared with 3473 of 4397 patients (79.0%) in the TI group (adjusted RD, 8.3%[95% CI, 6.3% to 10.2%]). However, patients randomized to receive TI were less likely to receive advanced airway management (3419 of 4404 patients [77.6%] vs 4161 of 4883 patients [85.2%] in the SGA group). Two of the secondary outcomes (regurgitation and aspiration) were not significantly different between groups (regurgitation: 1268 of 4865 patients [26.1%] in the SGA group vs 1072 of 4372 patients [24.5%] in the TI group; adjusted RD, 1.4%[95% CI, -0.6% to 3.4%]; aspiration: 729 of 4824 patients [15.1%] vs 647 of 4337 patients [14.9%], respectively; adjusted RD, 0.1%[95% CI, -1.5% to 1.8%]). CONCLUSIONS AND RELEVANCE Among patients with out-of-hospital cardiac arrest, randomization to a strategy of advanced airway management with a supraglottic airway device compared with tracheal intubation did not result in a favorable functional outcome at 30 days.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Economics

Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib

Simone Huygens, Heleen Vellekoop, Matthijs Versteegh, Irene Santi, Laszlo Szilberhorn, Tamas Zelei, Balzs Nagy, Apostolos Tsiachristas, Rositsa Koleva-Kolarova, Sarah Wordsworth, Maureen Rutten-van Molken, HEcoPerMed Consortium

Summary: This study addresses the challenges of evaluating histology-independent treatments using entrectinib as an example. It evaluates the cost-effectiveness of testing all patients for NTRK fusions and treating positive cases with entrectinib, compared to no testing and standard care. The results show that testing and treatment have higher costs and effects.

VALUE IN HEALTH (2023)

Article Dermatology

Remote assessment of surgical site infection (SSI) using patient-taken wound images: Development and evaluation of a method for research and routine practice

Rhiannon C. Macefield, Jane M. Blazeby, Barnaby C. Reeves, Anni King, Jonathan Rees, Anne Pullyblank, Kerry Avery

Summary: This study developed and evaluated a method for patients to capture standardized wound images for remote wound assessment to detect surgical site infection (SSI). The results showed that the method is simple, standardized, and acceptable, and high-quality images can be used for remote assessment of SSI.

JOURNAL OF TISSUE VIABILITY (2023)

Editorial Material Critical Care Medicine

Out-of-hospital cardiac arrest

Jerry P. Nolan, Katherine M. Berg, Janet E. Bray

INTENSIVE CARE MEDICINE (2023)

Review Anesthesiology

Post-Cardiac Arrest Syndrome

James Penketh, Jerry P. Nolan

Summary: Post-cardiac arrest syndrome (PCAS) is a complex condition that affects survivors of cardiac arrest. This review explores strategies for managing PCAS, including oxygenation, blood pressure control, coronary reperfusion timing, temperature control, and seizure treatment. Despite ongoing research, many questions about the optimal interventions for PCAS remain unanswered, and the role of intracranial pressure monitoring is still unclear.

JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY (2023)

Article Health Care Sciences & Services

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom

Catherine Hyams, Robert Challen, Robin Marlow, Jennifer Nguyen, Elizabeth Begier, Jo Southern, Jade King, Anna Morley, Jane Kinney, Madeleine Clout, Jennifer Oliver, Sharon Gray, Gillian Ellsbury, Nick Maskell, Luis Jodar, Bradford Gessner, John McLaughlin, Leon Danon, Adam Finn

Summary: This study demonstrates that Omicron infection in hospitalized patients results in lower disease severity compared to the Delta variant. Despite being relatively lower, Omicron infection still imposes a significant burden on patients and public health.

LANCET REGIONAL HEALTH-EUROPE (2023)

Article Anesthesiology

A quantitative evaluation of aerosol generation during cardiopulmonary resuscitation

A. J. Shrimpton, V. Brown, J. Vassallo, J. P. Nolan, J. Soar, F. Hamilton, T. M. Cook, B. R. Bzdek, J. P. Reid, C. H. Makepeace, J. Deutsch, R. Ascione, J. M. Brown, J. R. Benger, A. E. Pickering

Summary: Cardiopulmonary resuscitation generates high concentrations of respiratory aerosol, suggesting the need for airborne transmission precautions in high-risk pathogen settings.

ANAESTHESIA (2023)

Article Health Care Sciences & Services

Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies

Jessica Harris, Koen B. Pouwels, Thomas Johnson, Jonathan Sterne, Christalla Pithara, Kalaivani Mahadevan, Barney Reeves, Umberto Benedetto, Yoon Loke, Daniel Lasserson, Brett Doble, Noreen Hopewell-Kelly, Sabi Redwood, Sarah Wordsworth, Andrew Mumford, Chris Rogers, Maria Pufulete

Summary: This study quantified the bleeding risk among patients undergoing different antiplatelet and triple therapy regimens for percutaneous coronary intervention or coronary artery bypass grafting, as well as conservatively managed acute coronary syndrome. The results suggest that more potent dual antiplatelet therapy may increase the risk of bleeding without reducing the incidence of major adverse cardiovascular events.

HEALTH TECHNOLOGY ASSESSMENT (2023)

Article Pharmacology & Pharmacy

Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries

Laszlo Szilberhorn, Tamas Zelei, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Molken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Balazs Nagy

Summary: Correct diagnosis of MODY is important to provide appropriate treatment. Screening with the MODY calculator then genetic testing is considered cost-effective, and the addition of autoantibody testing can replace no screening. The budget impact ranges from 0.001% to 0.025% of annual public healthcare spending.

PERSONALIZED MEDICINE (2023)

Editorial Material Pharmacology & Pharmacy

HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead

Maureen Rutten-van Moelken, Matthijs Versteegh, Balazs Nagy, Sarah Wordsworth

PERSONALIZED MEDICINE (2023)

Article Pharmacology & Pharmacy

Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems

Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Molken, Laszlo Szilberhorn, Tamas Zelei, Balazs Nagy, Sarah Wordsworth, Apostolos Tsiachristas

Summary: The cost-effectiveness and budget impact of introducing extended DPYD testing with ToxNav prior to capecitabine/5-fluorouracil in metastatic breast cancer patients in the UK, The Netherlands, and Hungary were examined. ToxNav was cost-effective in all three countries and resulted in budget savings in the UK and The Netherlands.

PERSONALIZED MEDICINE (2023)

Article Pharmacology & Pharmacy

Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK

Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Moelken, Laszlo Szilberhorn, Tamas Zelei, Balazs Nagy, Sarah Wordsworth, Apostolos Tsiachristas

Summary: This study aimed to assess the cost-effectiveness of ToxNav (c), a multivariant genetic test, for screening DPYD and personalized chemotherapy dosing in metastatic breast cancer patients in the UK. Results showed that ToxNav (c) was dominant over standard of care, providing additional quality-adjusted life years and cost savings per patient. Sensitivity analysis further supported the effectiveness of the ToxNav (c) strategy.

PERSONALIZED MEDICINE (2023)

Article Pharmacology & Pharmacy

Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies

Balazs Nagy, Tamas Zelei, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Moelken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Laszlo Szilberhorn

Summary: The HEcoPerMed consortium developed a methodological guidance for economic evaluations in personalized medicine, and health economic models were developed to analyze the recommendations. The models addressed most of the recommendations and identified essential recommendations in each study.

PERSONALIZED MEDICINE (2023)

Article Anesthesiology

Peri-operative decisions about cardiopulmonary resuscitation among adults as reported to the 7th National Audit Project of the Royal College of Anaesthetists

J. P. Nolan, J. Soar, A. D. Kane, I. K. Moppett, R. A. Armstrong, E. Kursumovic, T. M. Cook

Summary: According to current guidance, cardiopulmonary resuscitation should be attempted when cardiac arrest occurs during anesthesia, and 'do not attempt cardiopulmonary resuscitation' recommendation should be suspended if a patient has it pre-operatively. However, how this guidance is implemented in everyday clinical practice in the UK is unknown. This study found that a small proportion of patients had a pre-existing 'do not attempt cardiopulmonary resuscitation' recommendation, and when cardiac arrest occurred, some patients achieved return of spontaneous circulation, but most of them died before discharge from the hospital.

ANAESTHESIA (2023)

Article Anesthesiology

Peri-operative cardiac arrest: management and outcomes of patients analysed in the 7th National Audit Project of the Royal College of Anaesthetists

R. A. Armstrong, T. M. Cook, A. D. Kane, E. Kursumovic, J. P. Nolan, F. C. Oglesby, L. Cortes, C. Taylor, I. K. Moppett, S. Agarwal, J. Cordingley, M. T. Davies, J. Dorey, S. J. Finney, S. Kendall, G. Kunst, D. N. Lucas, R. Mouton, G. Nickols, V. J. Pappachan, B. Patel, F. Plaat, B. R. Scholefield, J. H. Smith, L. Varney, E. Wain, J. Soar

Summary: This study describes the management and outcomes of peri-operative cardiac arrest in UK practice, highlighting the impact of factors such as arrest rhythm, patient age, surgical priority, and the cause of cardiac arrest on patient survival and functional outcomes.

ANAESTHESIA (2023)

Article Anesthesiology

The incidence of potentially serious complications during non-obstetric anaesthetic practice in the United Kingdom: an analysis from the 7th National Audit Project (NAP7) activity survey

A. D. Kane, T. M. Cook, R. A. Armstrong, E. Kursumovic, M. T. Davies, S. Agarwal, J. P. Nolan, J. H. Smith, I. K. Moppett, F. C. Oglesby, L. Cortes, C. Taylor, J. Cordingley, J. Dorey, S. J. Finney, G. Kunst, D. N. Lucas, G. Nickols, R. Mouton, B. Patel, V. J. Pappachan, F. Plaat, B. R. Scholefield, L. Varney, J. Soar

Summary: This study investigated the occurrence of complications during anesthesia in a national cohort. The results showed variations in the frequency of different types of complications, with higher rates in emergency surgeries. Factors such as age, ASA physical status, gender, urgency and extent of surgery, day of the week, and time of day were found to be associated with the occurrence of complications. These data can be valuable for risk assessment and obtaining patient consent.

ANAESTHESIA (2023)

No Data Available